AI assistant
Glimpse Group, Inc. — Director's Dealing 2024
Mar 5, 2024
34791_dirs_2024-03-05_d75c774d-b12a-42e4-8cd8-4eeecebd3b11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Glimpse Group, Inc. (VRAR)
CIK: 0001854445
Period of Report: 2024-02-29
Reporting Person: Bentovim Lyron L (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-29 | Stock Option (Right to Purchase) | $ | D | 90188 | Disposed | Common Stock (90188) | Direct | |
| 2024-03-01 | Stock Option (Right to Purchase) | $ | A | 72153 | Acquired | 2031-03-01 | Common Stock (72153) | Direct |
Footnotes
F1: Represents the forfeiture of fully vested options to purchase an aggregate of 90,188 shares of common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of options to purchase (i) 32,508 shares of common stock granted on August 1, 2018 with an exercise price of $4.00/share, (ii) 6,037 shares of common stock and 4,799 shares of common stock granted on September 1, 2019 with an exercise price of $4.00/share, (iii) 22,222 shares of common stock and 6,674 shares of common stock granted on January 1, 2020 with an exercise price of $4.50/share, (iv) 2,333 shares of common stock granted on May 1, 2020 with an exercise price of $4.50/share, (v) 1,167 shares of common stock granted on July 1, 2020 with an exercise price of $4.50/share, and (vi) 14,448 shares of common stock granted on January 1, 2021 with an exercise price of $4.50/share.
F2: The options in footnote (1) were to expire 10 years from their respective grant dates.
F3: Mr. Bentovim was granted options to purchase an aggregate of 72,153 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, consisting of (i) options to purchase 24,051 shares of common stock, at an exercise price of $3.00 per share, which options vest on March 1, 2025, (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.50 per share, which options vest on March 1, 2026, and (ii) options to purchase 24,051 shares of common stock, at an exercise price of $2.00 per share, which options vest on March 1, 2027. The foregoing options are set to expire seven years from the grant date.